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Summary box
 ► There is a deficit of health policy and systems re-
search (HPSR)- specific ethical guidance, particularly 
in relation to matters of justice.
 ► We call for interpreting the ethical principle of justice 
in a more expansive way for HPSR relative to bio-
medical research.
 ► Drawing on the rich justice literature from political 
philosophy and public health ethics, we propose a 
set of essential justice considerations to uphold this 
principle.
 ► These considerations are relevant for research 
funders, researchers, research ethics committees, 
policymakers, community organisations and others 
who are active in the HPSR field.
AbSTrACT
Health policy and systems research (HPSR) is increasingly 
being funded and conducted worldwide. There are 
currently no specific guidelines or criteria for the ethical 
review and conduct of HPSR. Academic debates on 
HPSR ethics in the scholarly literature can inform the 
development of guidelines. Yet there is a deficiency of 
academic bioethics work relating to justice in HPSR. This 
gap is especially problematic for a field like HPSR, which 
can entail studies that intervene in ways affecting the 
social and health system delivery structures of society. In 
this paper, we call for interpreting the principle of justice in 
a more expansive way in developing and reviewing HPSR 
studies (relative to biomedical research). The principle 
requires advancing health equity and social justice at 
population or systems levels. Drawing on the rich justice 
literature from political philosophy and public health ethics, 
we propose a set of essential justice considerations to 
uphold this principle. These considerations are relevant 
for research funders, researchers, research ethics 
committees, policymakers, community organisations and 
others who are active in the HPSR field.
InTroduCTIon
Health policy and systems research (HPSR) 
is increasingly being funded and conducted 
worldwide.1 In a global context of persistent 
disparities in access to high- quality health 
services, rising healthcare costs and with 
many households facing catastrophic levels of 
healthcare expenditure, demand for health 
system strengthening through robust HPSR 
is rapidly growing.2 3 The boundaries, defi-
nitions and characteristics of HPSR are still 
being debated, but emerging consensus is 
that HPSR is primarily defined by the ques-
tion it asks rather than its methodological 
approach. Central foci are the performance 
of health systems and their subcomponents 
(hardware: financing, governance, human 
resources, medical commodities and infor-
mation systems; and software: power, values 
and relationships), consideration of how links 
among the subcomponents shape perfor-
mance and how to strengthen health system 
performance over time.4 HPSR relies on a 
wide range of methods that span positivist 
traditions using fixed research designs, such 
as economic evaluations, randomised control 
trials and other epidemiological designs, and 
relativist traditions using flexible research 
designs such as qualitative case studies, 
ethnographic design and participatory action 
research.5 HPSR has strong synergies with 
research approaches, including implementa-
tion science, improvement science, delivery 
science, operational research and manage-
ment research (figure 1).6
There are currently no specific guidelines 
or criteria for the ethical review and conduct 
of HPSR.7 For this reason, research ethics 
committees at most institutions apply well- 
established biomedical research ethics review 
criteria and guidelines to HPSR.8 These 
guidelines include criteria related to three 
prominent principles of biomedical research 
ethics: respect for persons, beneficence and 
justice.9 This is problematic: while HPSR and 
traditional biomedical research share many 
ethical principles and concepts, the two fields 
differ in numerous ways, including in the 
ethical issues and considerations that arise.8 10 
This is arguably especially the case for issues 
and considerations related to the prin-
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Figure 1 HPSR (adapted from Hoffman et al6). HPSR, health policy and systems research.
understood in distributive terms—as the fair distribution 
of burdens and benefits—in biomedical research ethics. 
This is insufficient for HPSR, for which the consider-
ations are much more complex than purely distributive.
HPSR can entail studies that intervene in ways affecting 
the social and health service delivery structures of society 
and, thus, have implications for social justice, namely, 
whether social structures ensure people’s health, well- 
being and participation. It has often been identified as 
an essential means to produce the knowledge necessary 
to reduce health disparities between and within coun-
tries,11 12 and as having potential to improve our under-
standing of how to change the odds for marginalised 
populations to achieve healthy lives.13 However, there is 
also the potential for HPSR to have negative implications 
for social justice: the focus of HPSR or the way in which 
it is conducted can inadvertently undermine people’s 
health or well- being, or increase disparities in access to 
social and health service delivery structures.
For HPSR, a tailoring of the ethical design and review 
process is needed, with the WHO arguing there is a 
‘compelling need’ for HPSR- specific guidelines and 
criteria (Luyckx et al, p1)[10]. Yet there is a deficiency 
of academic bioethics work relating to justice in HPSR, 
with the majority of existing scholarship focusing on 
autonomy and informed consent.7 Some justice consid-
erations have been identified for the field,7 10 14 but they 
are not comprehensive. This gap is especially concerning 
for a field like HPSR, where the knowledge generated 
can have significant implications for health and social 
justice at population and systems levels. It is therefore 
imperative that justice considerations be articulated and 
discussed specifically, and guidance on addressing them 
be formulated, to inform the development of HPSR 
ethics guidelines.
In this paper, we begin by taking the position that the 
principle of justice itself should be interpreted in a more 
expansive way for HPSR (relative to biomedical research), 
in a way that is consistent with the foundational moral 
commitments of public health. Drawing on the rich 
justice literature from political philosophy and public 
health ethics, which has largely not yet informed HPSR 
ethics, we elaborate on what advancing justice means 
for the field of HPSR. We then describe what consid-
erations of justice are essential to take into account for 
HPSR to uphold that principle, not only in HPSR priority 
setting and funding allocation, but also in reviewing 
and designing HPSR projects and programmes. These 
considerations are addressed to funders, researchers, 
policymakers, practitioners, community organisations, 
research ethics committees and others who are active 
in the HPSR field. We conclude by discussing and 
responding to several possible objections to our proposed 
justice considerations for HPSR. We further note that our 
focus on justice should be considered in addition to, and 
not instead of, adherence to other ethical principles and 
values in HPSR.
HPSr’S underlyIng morAl CommITmenT To HeAlTH And 
SoCIAl juSTICe
Much HPSR, especially in low- income and middle- income 
countries (LMICs), is conducted with the ultimate 
aim of reducing health disparities between and within 
countries and enhancing health system performance 
for those considered disadvantaged and marginalised.8 
Recent work in bioethics suggests such an aim is neces-
sary to advance health and social justice globally,15 16 and 
advancing justice is consistent with foundational moral 
commitments for public health research, practice and 
policy.17–19 Upholding justice in HPSR calls for not only 
achieving a fair share of benefits and burdens for stake-
holders in programmes of research, but also advancing 
health equity and, ultimately, social justice at a popula-
tion or societal level.
To clarify what advancing justice means for HPSR, a 
definition of health and social justice is required. While 
acknowledging definitional controversies within philos-
ophy, a number of points of convergence and common-
ality do exist. First, theories of justice in health emphasise 
the fundamental value of health for all, independent 
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status, political beliefs and religion.18 20 Second, multiple 
theories purport that it is a priority and duty of justice to 
avert and alleviate disadvantage.18 20 21 Powers and Faden, 
for example, argue that the moral aims of public health 
are to improve health and other dimensions of well- 
being, with priority given to the needs of the systemati-
cally disadvantaged.18 Systematic disadvantage has been 
defined as being vulnerable to or having large short-
falls on a cluster of dimensions of well- being, including 
health, security from physical and psychological harm, 
attachments, self- determination, respect, and sense and 
imagination.18 21 A focus on structural injustices—social 
norms and institutions that create an unequal playing 
field—is especially important to identify, avert and alle-
viate disadvantage.22 23
Multiple theories of justice call for bringing disadvan-
taged individuals and groups up to a ‘sufficient’ level 
of health and well- being, that is, that which is required 
for a decent life over a ‘normal’ life span (such as 75 
years).18 24 25 To attain and maintain a sufficient level of 
health, individuals are entitled to (among other things) 
public health and healthcare systems that provide (1) 
universal/equitable access to quality healthcare services 
that they need and (2) protection against financial 
hardship due to out- of- pocket healthcare expendi-
tures through equitable prepayment health financing 
mechanisms.25 26 Access to broader social or structural 
determinants of health and well- being is necessary 
as well.20 25 In countries worldwide, this encompasses 
ensuring sufficient health for refugee and migrant popu-
lations (among others).22 27 In countries with a colonial 
history, this means ensuring Indigenous health (partic-
ularly in regard to access to quality nondiscriminatory 
healthcare services) and decolonising healthcare systems 
and broader social structures that shape health.28 29 In 
LMICs, supporting sufficient health and well- being for 
individuals and groups requires meaningful as opposed 
to tokenistic capacity strengthening of local and national 
public health, healthcare and health research systems, as 
well as in some cases direct support from high- income 
countries.16 The aim is for countries to become capable 
of ensuring equitable population health and well- being.
A growing number of theories of justice emphasise that, 
in addition to sufficient health and well- being, a focus 
should be on agency, participation and epistemic justice 
aimed at building relational or democratic equality.30–34 
Agency is the ability to act on behalf of what you have 
reason to value and entails participating in determining 
one’s own and society’s actions.31 Epistemic justice means 
giving proper respect to individuals as knowers and 
sources of information. Democratic participation and 
epistemic justice constitute a means for citizens to ensure 
that their needs and interests are raised and reflected in 
public policies. These theories have recently begun to be 
applied to health and support robust citizen or commu-
nity participation in health system decision- making.35 36 
Theories of justice also identify procedural requirements 
for decision- making about health matters, which describe 
how democratic participation should occur. They gener-
ally call for relying on deliberative democratic processes 
and norms, including reasonableness, inclusion, equal 
voice, accountability and transparency, to achieve just 
decision- making.25 37 38
Finally, theories of justice employ principles to assign 
specific parties specific responsibilities and obligations 
of justice. For example, ‘functional requirements’ or 
‘capability to act’ principles assign obligations of justice 
to those who, by their roles and resources, are best posi-
tioned to fulfil them.23 26 Applying these allocative prin-
ciples and others to the research context demonstrates 
that ethical responsibilities of justice fall not only on 
individual researchers but also on other parties, such as 
funders, research institutions, ethics review committees 
and governments.16 39
eSSenTIAl juSTICe ConSIderATIonS for HPSr
To support researchers and other actors in the HPSR 
community to give more central emphasis to the prin-
ciple of justice in HPSR priority setting, funding alloca-
tion, design and ethical review, we translate the general 
facets of health and social justice described previously 
into specific justice considerations for HPSR. We further 
identify which HPSR actors bear responsibility to consider 
them using the capability to act principle (table 1). While 
the considerations we identify may not be an exhaus-
tive list, they comprise a robust starting point that can 
be refined and expanded on in the future. Many would 
also apply to related research approaches, such as imple-
mentation science and operational research. The order 
in which the considerations are presented assumes the 
following typical sequence of events in research (we 
recognise variations to this order may occur in prac-
tice): priorities are set and funding calls made, and then 
research teams are assembled and projects designed in 
response. Only some projects are funded, which undergo 
ethics review and then, if approved, are implemented.
HPSr priority setting
For HPSR projects to help alleviate disadvantage and 
promote relational equality, there must be careful 
consideration of what research topics are the focus of 
funding calls, who selects those topics and who is ulti-
mately allocated funding. The priorities set by HPSR 
funders, who are largely based in high- income coun-
tries, strongly determine whether HPSR projects are 
designed to generate new knowledge to improve health-
care and systems for marginalised groups, communities 
and health system actors.
Global funding for HPSR is frequently focused on 
how to expedite the scale- up of priority services. It is 
less likely to address deeper, more structural factors 
influencing health system equity.40 Theories of justice 
in health, however, emphasise the importance of 
generating new knowledge about disparities in access 
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nature of such inequalities, their causes and how they 
might be addressed.16 When exploring the causes of 
such disparities, it is especially vital to generate informa-
tion not only about individuals’ behaviours and health 
agency (health knowledge, health- seeking skills and 
beliefs, and effective health decision- making) but also 
broader structural and social determinants.20–22 26 The 
latter includes the exercise of hidden power (structural 
and discursive) within and beyond the health system. 
(Structural power refers to institutional practices 
(formal rules and procedures) and norms that enhance 
the capacities or possibilities for action of some and 
limit those of others. Discursive power encompasses 
language and concepts that create meanings that lead 
individuals to think of the world in some ways but not 
others. By influencing how individuals think about the 
world, this form of power shapes one’s beliefs, prefer-
ences, sense of self and acceptance of the status quo).41 
The importance of addressing intersecting structural 
and social determinants of health is due to their poten-
tial to cause individuals to fall below or to remain 
below a sufficient level of health.18 A key consideration 
for HPSR is then: Do funding platforms and calls priori-
tise research on equity in health systems and their structural 
determinants?
HPSR is frequently entwined with Western funders’ 
frames and expectations about priorities. Often, at the 
macro level, Western understanding of global health 
issues dominate.42 Yet many scholars have pointed out 
that Western conceptualisations of health and well- 
being are not universally shared or relevant and can, 
indeed, be in sharp contrast to values and ideas held by 
some communities and groups.28 43 44 Bennett et al raise 
the concern: ‘it is unclear to what extent local actors 
in LMIC health systems would frame their research 
concerns in the same way as global stakeholders’.40 
Inclusion in research decision- making of those who 
have traditionally been its subjects can bring different, 
previously under- represented perspectives into 
research and begin to redress power imbalances.45 46 
This potentially builds relational equality in HPSR. It 
is thus essential that the process of setting the topic/
focus of funding platforms and calls be inclusive of 
actors from LMICs who have historically been excluded 
from such decisions. Funding priorities should not be 
determined solely by funders and experts from high- 
income countries. Another important consideration 
is then: Are local actors from LMICs included in making 
decisions about the topics of HPSR funding platforms and 
calls? There should be careful consideration of what 
expertise and which local actors to include and from 
what sectors. Three important categories of local actors 
are researchers, marginalised groups (eg, Indigenous 
and refugee) or health system actors (eg, nurses, 
community health workers, patients and subnational 
policymakers), and actors with the power to change 
the policies and practices that affect them (policy-
makers, healthcare providers, insurers, civil society 
organisations and community organisations). The 
latter category can encompass actors in sectors beyond 
health, for example, education, sanitation and law.
Kalinga argues that grants should ideally give local 
actors in LMICs ‘platforms to be authoritative sources of 
and experts on their cultures and communities’ (Kalinga, 
p3)[47]. Further considerations for HPSR are then: Do 
funding platforms and calls require or permit (co- )lead appli-
cants from LMICs? Do funding requirements ensure sufficient 
funding of local actors and institutions to perform their roles?
research teams
For HPSR projects to promote health equity, help alle-
viate disadvantage and promote epistemic justice, it is 
essential that the composition and functioning of the 
research team challenge current global injustices in 
global health research. Research teams must include 
researchers who understand the sociopolitical and 
historical background of the populations involved 
in their studies, including systematically disadvan-
taged populations. Ensuring inclusion of researchers 
from (or with deep knowledge of) these populations 
is an epistemic justice consideration in itself and will 
likely contribute to research studies being better 
informed and designed. Ideally, HPSR should be led by 
researchers from the countries, regions and communi-
ties being researched, with strong collaborations with 
other local actors to bring diverse perspectives and 
expertise as needed. Involving under- represented local 
actors (ie, marginalised groups and/or actors with 
health systems, depending on the research focus) also 
helps to address epistemic injustice and build relational 
equality.
Crucial considerations about research teams for HPSR 
are then: Does the research team include local researchers and 
other local actors from populations involved in the study or at 
least with deep knowledge about those populations? Will they 
be included as partners and decision- makers throughout the 
project: from selecting research questions and designing the study 
to dissemination? Are research team members familiar with the 
sociopolitical and historical background of populations involved 
in the study and the social inequalities they experience?
Given the historical and current global structural 
injustices in health and research systems, it may not 
always be possible to ensure a genuinely level playing 
field among research team members throughout the 
design and conduct of potentially important HPSR. 
For example, imbalances may arise between non- local 
researchers and local actors, or between different types 
of local actors on the research team. Such imbalances 
require transparency from the outset, and the incorpo-
ration of systemic efforts to transform the situation from 
one of research on or about communities and subpop-
ulations to research by and with their members. Two 
further considerations for HPSR are then: Are any inad-
equacies in research team composition and representation of 
local actors, especially marginalised groups and health system 
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undertaken for local actors who are part of the research team 
to strengthen their capacity to conduct independent HPSR? 
(We discuss capacity strengthening in more detail later 
in the paper).
research questions
For HPSR projects to promote agency and generate 
knowledge that will help improve health systems for those 
considered disadvantaged, there must be careful consid-
eration about what research questions are selected and by 
whom. Many voices, needs and agendas exist within the 
HPSR field: those of funders, global health actors, health 
systems researchers, policymakers, healthcare providers 
and communities. Given the imbalances outlined in 
previous sections, some voices are often excluded from 
question setting. LMIC researchers, for example, are 
often relegated to the role of ‘a glorified field worker’, 
responsible for providing samples or conducting inter-
views but excluded from the ‘creative, interesting and 
scientific’ features of the collaboration.48 A key consider-
ation for HPSR is then: Are local researchers and other local 
actors on the research team leading or, at a minimum, part of 
decision- making on the research question(s)? These will be 
local to specific HPSR projects and, therefore, will not 
necessarily be the same as the local actors included in 
research priority setting and research funding allocation.
Even where the content of research questions comes 
from local researchers, health system managers or poli-
cymakers, the questions prioritised may not align with 
those articulated by other local actors, especially those 
considered marginalised and disadvantaged within 
communities or health systems (This is a particular 
problem in societies with colonial past and present, 
with native populations questioning the legitimacy of 
settler governments, health policies and interventions, 
and their failure to incorporate Indigenous values and 
standpoints28 29).46 49 The community- based partic-
ipatory research literature highlights a continuum 
between the ‘utilisation- focused Northern tradition’ 
and the ‘emancipatory Southern tradition’.50 51 The 
former seeks to produce knowledge that addresses the 
real- world needs of policymakers and practitioners and 
facilitate its translation into action.50 In the Southern 
tradition, partnerships are formed with subpopulations 
considered to be disadvantaged and marginalised. In 
this tradition, research seeks to identify and transform 
the root causes or material circumstances that produce 
and reproduce social disparities and hierarchies; an 
approach that appears quite pertinent to whether 
HPSR advances health equity and social justice at the 
population and systems levels.50
Some argue that members of marginalised groups 
are best positioned to identify the most critical health 
issues and inequalities they face.45 Additional proce-
dural considerations are as follows: Will disadvantaged 
and marginalised groups or health system actors (or organi-
sations representing them) share decision- making as part of 
research teams or, at a minimum, be consulted in setting the 
research question(s)? How can such processes achieve norms of 
inclusion, accountability and transparency? This is consis-
tent with requirements of justice relating to agency, 
deliberation and participation.21 32 46
Contemporary theories of justice explicitly include other 
elements consistent with the so- called ‘Southern tradition’. 
They call for focusing attention on the importance of 
generating new knowledge about disparities within health 
systems—for example, in access to health services, financial 
protection, and treatment of health system actors—and 
exploring their social and structural determinants. For 
HPSR, this could mean exploring how such determinants 
interact to create poor access to health services and inade-
quate financial protection for systematically disadvantaged 
groups and what interventions can address them. Key 
considerations for HPSR are then: Do the research questions 
align with the priorities of disadvantaged and marginalised groups 
or health system actors? Will answering the research question(s) 
create new knowledge of value for equitable health systems? This 
calls for HPSR to generate new knowledge about how to 
achieve fair treatment of marginalised health system actors 
and/or how to improve access and financial protection for 
marginalised groups. It is consistent with the requirement 
of justice to prioritise (or focus on) the needs of those 
considered disadvantaged.18 21 34
research populations
For HPSR projects and programmes to help alleviate 
disadvantage in relation to health, there must be careful 
consideration about who comprises the research popula-
tion. This encompasses the selection of research popula-
tions and the recruitment of individual participants into 
studies.
According to Cassell and Young, ‘[w]here (HPSR) 
contributes to the planning of services and policy-
making, the voice of the socially excluded may be 
muffled, and that of the better educated and materially 
secure, artificially amplified’. (p316)52 Entire geograph-
ical areas or subpopulations that are marginalised or 
disadvantaged (eg, certain districts or wealth groups 
and types of health system actors) can be excluded 
from studies. Within selected research areas or popula-
tions, disadvantaged and marginalised groups or health 
system actors can also be excluded from participating in 
studies. For example, within host districts, marginalised 
groups may not be reached by recruitment materials 
for HPSR studies. Participants in HPSR and emergent 
learning from studies will then only represent and 
reflect the experiences of a limited, better- off or more 
visible subset of the population. This means studies may 
misrepresent and misunderstand disadvantaged and 
marginalised groups’ and health system actors’ expe-
riences, or generate knowledge and learnings that do 
not strongly apply to such subpopulations. In so doing, 
research processes and outputs may inadvertently exac-
erbate, rather than reduce, unacceptable differences in 
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A key consideration for HPSR studies is then: Does the 
research population and participants adequately include disad-
vantaged and marginalised groups and health system actors? 
‘Adequate inclusion’ could mean that HPSR studies 
either focus on particular disadvantaged or marginalised 
groups or health system actors to produce new knowledge 
with the potential to transform their situation, or suffi-
ciently include such groups and actors in the research 
population to ensure that disadvantage and margin-
alisation are better understood and highlighted. The 
latter would enable HPSR to generate data that support 
comparisons between better- off and worst- off groups, and 
between more and less visible groups. For quantitative 
studies, adequate inclusion can, for example, produce 
knowledge of difference or equivalence of health or 
health system issues across different social or geograph-
ical stratifiers, or intersections between several stratifiers. 
For qualitative studies, it can support, for example, explo-
ration of the lived realities of those groups and health 
system actors considered disadvantaged or marginalised 
and help them identify their own abilities and vulnerabil-
ities (including structural drivers behind revealed vulner-
abilities inequities).
Working towards adequate inclusion requires recog-
nition that members of some structurally marginalised 
groups might have good reasons to avoid or be suspi-
cious about participation in research.46 Many scholars 
have emphasised the crucial role of community 
engagement in building trust between researchers and 
communities.45 47 53 Community engagement can also 
support inclusive participant recruitment strategies. An 
important concern for some HPSR studies is then: Will 
research project recruitment be informed by and respectful of 
marginalised groups’ past experiences with research and will 
meaningful engagement be conducted? This is consistent 
with the requirements of justice relating to building 
relational equality.
Identifying and responding to harms
To ensure HPSR projects do not exacerbate existing 
disadvantage and widen disparities in health and well- 
being requires anticipation and monitoring of negative 
effects that fall disproportionately on local actors.15 45 46 
These include medical (physical and psychological), 
social, economic and political harms.8 Here, there is a 
special interest in hearing about any issues and harms 
that are anticipated or experienced by those who have 
the least voice and power within research teams, health 
systems and communities. Among research teams, 
unequal power dynamics can prevent local actors, for 
example, from respecting local social customs and 
codes.47 An ethical consideration for HPSR is then: Will 
engagement and communication systems be set up that antic-
ipate and keep track of harms generated by HPSR for local 
actors who are potentially disadvantaged and marginalised 
within research teams, health systems and communities? This 
is consistent with the requirements of justice relating 
to epistemic justice and participation. The harms 
identified for local actors within and external to the 
research team will likely differ and require different 
approaches to mitigate or resolve.
To ensure that HPSR projects do not widen existing 
disparities further entails acting on anticipated harms 
where monitoring processes suggest that HPSR is having 
negative impacts. Efforts should be taken to develop 
and implement strategies to minimise anticipated and 
identified harms. Another ethical consideration for 
HPSR is then: How will the study team act to minimise and 
address anticipated harms and issues that eventuate to disad-
vantaged and marginalised groups and health system actors 
while also ensuring that the integrity of the science and the 
learning—especially about the most vulnerable within systems 
and communities—is maintained?
research capacity development and health system 
strengthening
Promoting health of those considered disadvantaged 
and marginalised requires strengthening in- country 
capacity to deliver health services and lead essential 
health research, especially in LMICs. All HPSR projects 
and programmes in LMICs, whether initiated within 
countries or by external researchers, should contribute 
to the sustainable development of health systems and 
health research systems. Building researchers’ and insti-
tutions’ capacities to drive nationally relevant HPSR is a 
key aspect of achieving that goal. Ethical considerations 
for HPSR studies include Do funding platforms require and 
support strengthening individual and institutional capacity 
within LMICs to conduct independent HPSR? How will the 
project’s design, implementation, publications and data sharing 
plans further those aims? How will the study strengthen study 
participants’ health systems?
It is also critical that HPSR does not exacerbate 
disparities in research capacity and career develop-
ment, especially between LMIC researchers and high- 
income country researchers or between non- Indigenous 
and Indigenous researchers. This could happen, for 
example, where LMIC or Indigenous researchers’ roles 
are limited to data collection, rather than contributing 
to the entire research process, or where these individ-
uals are inappropriately excluded from authorship. It 
could also happen where data sharing arrangements 
undermine LMIC or Indigenous researchers’ oppor-
tunity to analyse and publish their datasets. Another 
ethical consideration for HPSR is: How will the project’s 
design, implementation, publications and data sharing plans 
minimise the risk of worsening disparities in research capacity?
Creating lasting change
For HPSR to help improve health systems for those 
considered disadvantaged and marginalised, the knowl-
edge and learning it generates must be used to inform 
health system reform, public health and social action. 
Theories of justice contend that ensuring that individ-
uals and groups have sufficient health requires not only 
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health systems and social policies right. Health system 
reform and public health efforts should, therefore, 
ideally inform policies and practices in sectors beyond 
health like housing, education, urban planning and 
income.18 20 25 This requires promoting the translation 
of HPSR findings into health and social policy and prac-
tice in ways that help reduce health disparities.54 This, in 
turn, necessitates executing strategies for promoting the 
use of HPSR findings by local actors, namely, disadvan-
taged and marginalised groups and health system actors 
and/or those actors with the power to change policies 
and practices that affect them. An ethical consideration 
for HPSR projects is then: Does the funding platform require 
and support knowledge translation of HPSR findings into 
health and social policy and practice? What efforts will be made 
to maximise positive outcomes or benefits poststudy for disadvan-
taged and marginalised groups and health system actors? How 
are actors with the power to change health and social policies 
engaged?
research funding allocation and ethics review
Whether HPSR helps alleviate disadvantage and builds 
relational equality is determined by which projects are 
ultimately awarded funding. Concern has been raised 
that some donors primarily fund HPSR in LMICs on a 
narrow set of questions related to service delivery and 
scale up rather than HPSR that is responsive to local 
needs or focused on equity.47 55 A key consideration 
is then: Is funding allocated to HPSR research teams and 
projects that have been assembled and designed with justice 
considerations in mind? To support building relational 
equality, research funders should include local actors 
from LMICs on grant review panels and as advisors 
when making funding decisions. It is thus important 
to consider: Do decisions about research funding allocation 
include local actors from LMICs?
Prior to implementation, ethics review committees 
should assess funded projects for many of the proposed 
justice considerations (table 1). Projects should ideally 
also be monitored during implementation, with ethics 
review committees empowered and resourced to step in 
where justice considerations are being ignored in ways that 
could exacerbate existing inequities in health and research 
capacity. Such continuous review would mark a change 
in practice for many ethics committees worldwide and 
would require strong, well- trained and supported ethics 
committees.
AddreSSIng PoTenTIAl objeCTIonS
Several objections can be anticipated to our proposed 
essential considerations of justice for HPSR. Justice, 
in itself, is a contested term, with various interpreta-
tions existing in the philosophy and ethics literatures. 
This raises the question: how can demands of justice 
be fulfilled in HPSR if there is no unanimous agree-
ment on the concept of justice in general? Beyond this, 
from a practical perspective, how can the demands of 
justice feasibly be achieved if their realisation is highly 
complex? To address the first matter, we have sought 
to rely on points of commonality and convergence 
among theories of justice to identify the proposed 
justice considerations for HPSR. We further empha-
sise that justice considerations require an ongoing 
process of debate and revision, in constant exchange 
with theorists in the area of health justice, as well as 
with researchers, policymakers, community organisa-
tions and others in the HPSR field. Such dialogue can 
consider whether the justice considerations are too 
demanding to achieve in real- world practice and iden-
tify what structural changes may be required to facili-
tate their being upheld. Fomenting and sustaining this 
dialogue is the responsibility of all HPSR actors as well 
as ethicists (who may or may not focus on HPSR and 
thus may or may not see themselves as HPSR actors).
Another related challenge to our proposed consid-
erations of justice is that their implementation might 
obstruct or slow down the conduct of HPSR at a time 
when the need for HPSR is widely recognised. A more 
inclusive study design that aims to explicitly address 
disadvantaged groups’ needs might require including, 
for example, migrants who do not speak the language 
of the host country; individuals living with disability, 
illiteracy or dyslexia who might need assistance to 
participate; or geographically remote individuals 
whose participation is costly and logistically difficult to 
achieve. This might create higher costs, require more 
research staff, and slow down studies and learning. 
Does the goal of achieving their inclusion as a matter of 
justice justify the increase in resources and time neces-
sary to attain it? We cannot offer a general solution to 
this problem. How marginalised groups and health 
system actors can best be included should be decided 
on a case- by- case basis. Our proposal is certainly not 
intended to unnecessarily complicate the research 
process, and every HPSR project will need to weigh up 
the advantages and disadvantages of different inclu-
sion mechanisms. In so doing, however, it should be 
recognised that by designing more inclusive research 
projects, HPSR will most likely produce results that 
better reflect the heterogeneous reality and thus help 
develop more responsive and effective health system 
practices and policies. Thus, for both justice and data 
validity reasons, it is likely to be valuable to embrace 
and understand diverse—including historically margin-
alised—perspectives in study designs.
It could be argued that a considerable amount of HPSR 
takes place in high- income countries, where disadvan-
tage and health inequity are not as severe as in LMICs. 
Is it then necessary and appropriate for the proposed 
considerations of justice to apply to HPSR worldwide or 
primarily to HPSR in LMICs? We acknowledge that there 
are settings in which injustices might be particularly stark 
and where a focus on HPSR’s procedural and substantive 
contributions to justice is especially needed. Nevertheless, 
all societies experience disadvantage, stigmatisation and 
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is very wide in some high- income countries. We therefore 
suggest that the proposed justice considerations be taken 
into account for HPSR in all countries.
Lastly, we acknowledge that tensions may well exist 
between the procedural and substantive considerations 
that we identify. For example, research questions identified 
with the input of disadvantaged and marginalised groups 
may not always create strong new knowledge for equi-
table health systems. More broadly, there may be tensions 
between the proposed justice considerations and ethical 
considerations reflecting other values in HPSR (eg, soli-
darity and beneficence). We emphasise the need for addi-
tional conceptual and empirical work to explore the nature 
of these tensions and how they can be navigated.
ConCluSIonS
We have proposed that the principle of justice should 
be interpreted more expansively for HPSR than is 
routinely the case for biomedical research. To uphold 
this principle, we have identified a set of essential 
justice considerations to more centrally incorporate 
justice into HPSR priority setting, funding allocation, 
design and ethical review. We recognise the large 
range of study designs and methodological approaches 
encapsulated in HPSR, and the diversity in their scope 
and size, and that there are many HPSR projects that 
already have justice built in as a core concern and 
approach. By articulating these considerations, we hope 
to raise the prominence of dimensions of justice as key 
ethical considerations in HPSR across different types of 
studies. Taking the proposed justice considerations into 
account should promote those active in the HPSR field 
to more systematically link projects and programmes to 
the promotion of health equity and social justice at the 
population and systems levels.
Twitter Edwine Barasa @edwinebarasa, Lucy Gilson @Lucy_Gilson and Sassy 
Molyneux @sassy.molyneux
Acknowledgements We thank the speakers and attendees of the WHO Experts 
Meeting on Ethical Review for Health Policy and Systems Research, held at the 
University of Zurich on 23–24 July 2015. Our discussions as part of this meeting 
informed the thinking that is reflected in this paper. We also thank Vicki Marsh, 
Sridhar Venkatapuram and the two anonymous BMJ Global Health reviewers for 
providing insightful and constructive comments on earlier versions of this paper.
Contributors BP, VW and SM conceived of and wrote the first draft of the paper, 
with BP taking the lead. Each substantially contributed to the analyses presented 
in the paper. TH, EB, LG and DK each contributed substantially to the intellectual 
content of the paper and were involved in revising paper. All authors approved the 
submitted version of the paper.
funding BP is currently supported by an Australian Research Council (ARC) 
Discovery Early Career Researcher Award (award number DE170100414). The 
contents of this article are solely the responsibility of the author and do not reflect 
the views of the ARC. VW and TH are supported by the German Federal Ministry 
(BMBF, FKZ 01GP1791). SM and DK are supported by a Wellcome Trust Strategic 
Award to the Global Health Bioethics Network (096527), and SM by a Wellcome 
Trust Collaborative Award and by Nuffield Department of Medicine funds at the 
University of Oxford. DK is also funded by the Wellcome Trust Humanities and 
Social Science (Society and Ethics) (grant number 205419/Z/16/Z).
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement There is no data for this article.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
orCId ids
Bridget Pratt http:// orcid. org/ 0000- 0002- 4934- 3560
Edwine Barasa http:// orcid. org/ 0000- 0001- 5793- 7177
REFEREncEs
 1 Alliance for Health Policy and Systems Research. World report 
on health policy and systems research. Geneva: World Health 
Organization, 2017.
 2 World Health Organization. World health report 2013: research for 
universal health coverage. Geneva: World Health Organization, 
2013.
 3 World Health Organization. Health systems financing: the path to 
universal coverage. Geneva: World Health Organization, 2010.
 4 Sheikh K, Gilson L, Agyepong IA, et al. Building the field of health 
policy and systems research: framing the questions. PLoS Med 
2011;8:e1001073.
 5 Gilson L, Hanson K, Sheikh K, et al. Building the field of health 
policy and systems research: social science matters. PLoS Med 
2011;8:e1001079.
 6 Hoffman SJ, Røttingen J- A, Bennett S, et al. Background paper on 
conceptual issues related to health systems research to inform a 
who global strategy on health systems research, 2012. Available: 
http://www. who. int/ alliancehpsr/ alliancehpsr_ back grou ndpa perh 
srstrat1. pdf [Accessed 14 Jul 2013].
 7 Pratt B, Paul A, Hyder AA, et al. Ethics of health policy and systems 
research: a scoping review of the literature. Health Policy Plan 
2017;32:890–910.
 8 Hyder AA, Rattani A, Krubiner C, et al. Ethical review of health 
systems research in low- and middle- income countries: a conceptual 
exploration. Am J of Bioeth 2014;14:28–37.
 9 Beauchamp TL, Childress JF. Principles of biomedical ethics. 7th 
edn. Oxford: Oxford University Press, 2013.
 10 Luyckx VA, Biller- Andorno N, Saxena A, et al. Health policy and 
systems research: towards a better understanding and review of 
ethical issues. BMJ Glob Health 2017;2:e000314.
 11 World Health Organization Task Force on Health Systems Research. 
The millennium development goals will not be attained without new 
research addressing health system constraints to delivering effective 
interventions. Geneva: WHO, 2005.
 12 Ministerial Summit on Health Research. The Mexico statement on 
health research. Mexico City, 2004.
 13 Plough AL. Building a culture of health: a critical role for public 
health services and systems research. Am J Public Health 
2015;105:S150–2.
 14 Alliance for Health Policy and Systems Research (WHO) with the 
Global Health Ethics Unit (WHO). Ethical Considerations for Health 
Policy and Systems Research. Geneva: World Health Organization, 
2019.
 15 Faden RR, Kass NE, Goodman SN, et al. An ethics framework for 
a learning health care system: a departure from traditional research 
ethics and clinical ethics. Hastings Cent Rep 2013;43:S16–27.
 16 Pratt B, Hyder AA. Global justice and health systems research 
in low- and middle- income countries. J Law Med Ethics 
2015;43:143–61.
 17 Baylis F, Kenny NP, Sherwin S. A relational account of public health 
ethics. Public Health Ethics 2008;1:196–209.
 18 Powers M, Faden R. Social Justice: The Moral Foundations of Public 
Health and Health Policy. New York: Oxford University Press, 2006.
 19 Rogers WA. Feminism and public health ethics. J Med Ethics 
2006;32:351–4.
 20 Wolff J, de- Shalit A. Disadvantage. Oxford, UK: Oxford University 
Press, 2007.
 21 Venkatapuram S. Health Justice: An Argument from the Capabilities 
Approach. Cambridge: Polity Press, 2011.
 22 Chung R, Hunt M, Lenard PT, et al. Justice and health inequalities 
in humanitarian crises: Structured health vulnerabilities and natural 
disasters. In: Health inequalities and global justice. Edinburgh: 















ealth: first published as 10.1136/bm





Pratt B, et al. BMJ Global Health 2020;5:e001942. doi:10.1136/bmjgh-2019-001942 11
BMJ Global Health
 23 Young IM. Responsibility and global justice: a social connection 
model. Soc Philos Policy 2006;23:102–30.
 24 Nussbaum MC. Frontiers of justice: disability, Nationality, species 
membership. Cambridge, MA: Belknap Press of Harvard University 
Press, 2006.
 25 Daniels N. Just Health: Meeting Health Needs Fairly. Cambridge: 
Cambridge University Press, 2008.
 26 Ruger JP. Health and social justice. Oxford: Oxford University Press, 
2010.
 27 Wild V, Dawson A. Migration: a core public health ethics issue. 
Public Health 2018;158:66–70.
 28 Sherwood J, Edwards T. Decolonisation: a critical step for improving 
Aboriginal health. Contemp Nurse 2006;22:178–90.
 29 Fay J. Decolonising mental health services one prejudice at a time: 
psychological, sociological, ecological, and cultural considerations. 
Settler Colonial Studies 2018;8:47–59.
 30 Sen A. Development as freedom. New York: Knopf Press, 1999.
 31 Young IM. Justice and the Politics of Difference. Princeton University 
Press: Princeton, 1990.
 32 Fricker M. Epistemic Injustice: Power and the Ethics of Knowing. 
Oxford University Press: Oxford, 2007.
 33 Anderson ES. What is the point of equality? Ethics 
1999;109:287–337.
 34 Khader S. Decolonizing Universalism: A Transnational Feminist Ethic. 
Oxford University Press, 2018.
 35 Voigt K, Wester G. Relational equality and health. Soc Phil Pol 
2015;31:204–29.
 36 Blease C, Carel H, Geraghty K. Epistemic injustice in healthcare 
encounters: evidence from chronic fatigue syndrome. J Med Ethics 
2017;43:549–57.
 37 Gilson L. In defence and pursuit of equity. Soc Sci Med 
1998;47:1891–6.
 38 Gutmann A, Thompson D. Why Deliberative democracy? Princeton, 
NJ: Princeton University Press, 2004.
 39 London AJ. Justice and the human development approach to 
international research. Hastings Cent Rep 2005;35:24–37.
 40 Bennett S, Agyepong IA, Sheikh K, et al. Building the field of health 
policy and systems research: an agenda for action. PLoS Med 
2011;8:e1001081.
 41 Gilson L, Doherty J, Lowenson R, et al. Challenging inequity through 
health systems: final report of the knowledge network on health 
systems. WHO Commission on the social determinants of health. 
Johannesburg: Centre for Health Policy, EQUINET, London School of 
Hygiene and Tropical Medicine, 2007.
 42 Gautier L, Sieleunou I, Kalolo A. Deconstructing the notion of "global 
health research partnerships" across Northern and African contexts. 
BMC Med Ethics 2018;19:49.
 43 Nie J- B. The plurality of Chinese and American medical moralities: 
toward an interpretive cross- cultural bioethics. Kennedy Inst Ethics J 
2000;10:239–60.
 44 Pillay M, Kathard H. Decolonizing health professionals' education: 
audiology & speech therapy in South Africa. African Journal of 
Rhetoric 2015;7:193–227.
 45 Jamieson LM, Paradies YC, Eades S, et al. Ten principles relevant 
to health research among Indigenous Australian populations. Med J 
Aust 2012;197:16–18.
 46 Tuhiwai Smith L. Decolonizing methodologies: research and 
Indigenous peoples. 2nd edn. London: Zed Books, 2012.
 47 Kalinga C. Caught between a rock and a hard place: navigating 
global research partnerships in the global South as an indigenous 
researcher. J Afr Cult Stud 2019;31:270–2.
 48 Parker M, Kingori P. Good and bad research collaborations: 
researchers' views on science and ethics in global health research. 
PLoS One 2016;11:e0163579.
 49 MacGregor H, Bloom G. Health systems research in a complex 
and rapidly changing context: ethical implications of major health 
systems change at scale. Dev World Bioeth 2016;16:158–67.
 50 Cargo M, Mercer SL. The value and challenges of participatory 
research: strengthening its practice. Annu Rev Public Health 
2008;29:325–50.
 51 Wallerstein N, Duran B. The theoretical, historical, and practical 
roots of CBPR. In: Wallerstein N, Minkler M, eds. Community- based 
Participatory Research for Health: From Process to Outcome. San 
Francisco, CA: John Wiley & Sons, 2010: 25–46.
 52 Cassell J, Young A. Why we should not seek individual informed 
consent for participation in health services research. J Med Ethics 
2002;28:313–7.
 53 Gray MA, Oprescu FI. Role of non- Indigenous researchers in 
Indigenous health research in Australia: a review of the literature. 
Aust Health Rev 2016;40:459–65.
 54 Pratt B, Hyder AA. Linking participatory action research on health 
systems to justice in global health: a case study of the maternal and 
neonatal implementation for equitable health systems project in rural 
Uganda. J Empir Res Hum Res Ethics 2018;13:74–87.
 55 Gonzalez- Block MA. Health policy and systems research agendas in 















ealth: first published as 10.1136/bm
jgh-2019-001942 on 8 A
pril 2020. D
ow
nloaded from
 
